Panthera Biopartners
Kiruba Nanthini Kamal Raj M.Pharm, MRPharmS has over 8 years of work experience in the pharmaceutical field. Kiruba Nanthini began their career in 2013 as a Health Care Assistant at Care@NorthWest ltd. In 2017, they took on the role of Pre-Registration Pharmacist at the Hub Pharmacy. In 2018, they took on a two-week Pre-Registration Cross Sector Placement at Blackpool Victoria Hospital, where they learned to take drug histories and observed medicines reconciliation and discharge letters in all specialities. Kiruba Nanthini also observed how to use Emis system and had the chance to watch a CABG surgery. In 2019, they were appointed Clinical Lead Pharmacist and Locum Pharmacist at the Hub Pharmacy. In 2020, they took on the role of Clinical Pharmacist at East Lancashire Hospitals NHS Trust. In 2021, they worked as a Clinical Trial Pharmacist at MAC Clinical Research and as a Locum Clinical Pharmacist at University Hospitals of Morecambe Bay NHS Foundation Trust. Finally, in 2022, they were appointed Lead Pharmacist and Regional Research Pharmacist at Panthera Biopartners, and Consultant-Clinical Trial Pharmacist/ Director at KKRC Healthcare Limited.
Kiruba Nanthini Kamal Raj has a comprehensive educational background. Kiruba Nanthini obtained their Secondary School Leaving Certificate from Cheyyar Government Boys High School in 1993-1994, followed by a Higher Secondary School degree from Holy Cross Matriculation School, Vellore in 1994-1996. Kiruba Nanthini then completed a Diploma in Pharmacy from Anna University in 1996-1998. Following this, they earned a Bachelor of Business Administration - BBA from University of Madras in 1999-2005. In 2013-2017, they obtained a Masters of Pharmacy from University of Central Lancashire in the field of Pharmacy. Most recently, in 2020-2021, they earned a Postgraduate Certificate in Clinical Pharmacy Practice from Robert Gordon University.
This person is not in any offices
Panthera Biopartners
1 followers
Panthera Biopartners, established in 2019, is a leading UK-based Site Management Organisation (SMO) specialising in patient recruitment and the execution of clinical trials across various therapeutic areas. Founded by Dr Ian Smith, the originator of Synexus, and Professor John Lyon, a former global executive at Covance, Panthera has rapidly expanded its network to include dedicated clinical trial sites in major UK cities such as Glasgow, London, Manchester, Preston, Sheffield and York The organisation's mission is to enhance healthcare accessibility by conducting clinical research that integrates diverse insights and expertise. Panthera is committed to maintaining rigorous ethical standards and contributing to medical advancements that positively impact health and well-being. Panthera's management team comprises experienced professionals with extensive knowledge in conducting clinical trials across multiple therapy areas and countries. Key figures include Dr Ian Smith (Co-Founder, Director, and Chief Medical Officer), Stuart Young (Chief Executive Officer), and Chris Dodd (Chief Commercial Officer). In October 2024, Panthera became the first UK clinical trial site organisation to join Parexel’s Site Alliance Vaccine Network, a global consortium of high-performing clinical trial sites. This collaboration underscores Panthera's exceptional performance in patient recruitment and its strong partnership with Parexel. Panthera's dedication to innovation and excellence was recognised in October 2023 when it was named Pharma Research Centre of the Year at the Pharma Industry Awards UK. The award highlighted Panthera's innovative SMO model, which emphasises rapid start-up times, access to a vast pool of prequalified patients, and the digitisation of patient engagement processes.